Archives for June 30, 2005

← 2005

GSK says Paxil CR manufacturing problems are over

UK-headquartered pharma giant GlaxoSmithKline says it has overcome the manufacturing problems that caused it to voluntarily withdraw its antidepressant Paxil CR (paroxetine) and diabetes drug Avandamet (metformin and rosiglitazone) from the US market...

Silver antimicrobial use granted US patent

An ionic silver complex designed for human antimicrobial use has received a US patent, in a move that could well see increased usage of this technology that exhibits broad-spectrum antimicrobial qualities as well as displaying a lack of causing...

Qiagen buys Nextal tools for €8 millon

Dutch nucleic acid specialist, Qiagen, has entered into an agreement to acquire Nextal Biotechnology, a provider of sample preparation tools which make protein crystallisation more accessible. The deal also signals Qiagen's intention towards...

EMEA finalises EU pharma guideline procedure

The European Medicines Agency (EMEA) has finalised a new procedure designed to make the process for the development, consultation, finalisation and implementation of pharmaceutical guidelines clearer.